| P2093 | author name string | Adam Doyle | |
| | Prithi Bhathal | |
| | Ferry Rusli | |
| P2860 | cites work | Case of presymptomatic aceruloplasminemia treated with deferasirox | Q86954678 |
| | Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis | Q28270814 |
| | A case of hereditary ceruloplasmin deficiency with iron deposition in the brain associated with chorea, dementia, diabetes mellitus and retinal pigmentation: administration of fresh-frozen human plasma | Q30583066 |
| | Aceruloplasminaemia with progressive atrophy without brain iron overload: treatment with oral chelation | Q31131839 |
| | Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation | Q34329790 |
| | Use of desferrioxamine in the treatment of aceruloplasminemia | Q34419336 |
| | Aceruloplasminemia | Q34751964 |
| | The role of ceruloplasmin in iron metabolism | Q35582301 |
| | Aceruloplasminemia: a rare disease - diagnosis and treatment of two cases | Q36153657 |
| | Copper and iron disorders of the brain | Q36762463 |
| | The neurological presentation of ceruloplasmin gene mutations | Q37230833 |
| | Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family | Q42485956 |
| | Aceruloplasminemia: new clinical, pathophysiological and therapeutic insights | Q44014364 |
| | Treatment of symptomatic heterozygous aceruloplasminemia with oral zinc sulphate | Q48269852 |
| | Desferrioxamine treatment of aceruloplasminemia: Long-term follow-up | Q84146241 |
| P577 | publication date | 2015-05-14 | |
| P1433 | published in | BMJ case reports | Q27723081 |
| P1476 | title | Aceruloplasminaemia: a rare but important cause of iron overload | |
| P478 | volume | 2015 | |